De Novo device
PainChek (PainChek Adult)
Painchek Limited (Ltd.) · Pain Assessment Software In Non-Communicative Adults (SGB, Class II) · First FDA decision Oct 6, 2025, newest Oct 6, 2025Chronic pain
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
1
Naming "PainChek"
MAUDE reports
0
Brand "PainChek", since 2015
PubMed studies
30
Mentioning "PainChek"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing PainChek (PainChek Adult)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- PainChek (PainChek Adult)New device typeDe Novo
DEN240073 · Decided Oct 6, 2025 · 299 days after receipt
Device type: Pain Assessment Software In Non-Communicative Adults (SGB) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "PainChek", any status and sponsor, newest update first.
PainChek LtdNot on our public-company list
NCT06049732 · 105 participants · Start Oct 17, 2023 · Primary completion Jun 18, 2024
Device: PainChek® · For: Dementia; Pain
Sites: Cedar Falls, Iowa; Cedar Rapids, Iowa; Dubuque, Iowa · 5 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "PainChek", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SGB
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "PainChek"[tiab]. The summary above synthesizes these.
- Associations between facial expressions and observational pain in residents with dementia and chronic pain.
Pu L, Coppieters MW, Smalbrugge M, et al. · J Adv Nurs · 2024
- The Clinical Suitability of an Artificial Intelligence-Enabled Pain Assessment Tool for Use in Infants: Feasibility and Usability Evaluation Study.
Hughes JD, Chivers P, Hoti K · J Med Internet Res · 2023Research Support, Non-U.S. Gov't
- Digital Pain Assessment: Patient and Family Perspectives.
Saunders R, Crookes K, Nosaka K, et al. · Nurs Rep · 2026
- Parental Assessment of Postsurgical Pain in Infants at Home Using Artificial Intelligence-Enabled and Observer-Based Tools: Construct Validity and Clinical Utility Evaluation Study.
Sada F, Chivers P, Cecelia S, et al. · JMIR Pediatr Parent · 2024
- Assessing procedural pain in infants: a feasibility study evaluating a point-of-care mobile solution based on automated facial analysis.
Hoti K, Chivers PT, Hughes JD · Lancet Digit Health · 2021Research Support, Non-U.S. Gov't
- Implementing PainChek and PARO to Support Pain Assessment and Management in Residents with Dementia: A Qualitative Study.
Pu L, Coppieters MW, Smalbrugge M, et al. · Pain Manag Nurs · 2023Research Support, Non-U.S. Gov't
- Protocol for a usability and pilot implementation study of a digital medical device to assess pain in non-verbal people with dementia in Portuguese residential care facilities.
Pereira Guerreiro M, Félix IB, Tomé M, et al. · Digit Health · 2025
- Evaluation of the Psychometric Properties of PainChek® in UK Aged Care Residents with advanced dementia.
Babicova I, Cross A, Forman D, et al. · BMC Geriatr · 2021
- Feasibility study protocol of the PainChek app to assess the efficacy of a social robot intervention for people with dementia.
Pu L, Coppieters MW, Byrnes J, et al. · J Adv Nurs · 2022Clinical Trial Protocol
- Pain in Dementia: Prevalence and Association With Neuropsychiatric Behaviors.
Atee M, Morris T, Macfarlane S, et al. · J Pain Symptom Manage · 2021Research Support, Non-U.S. Gov't
- Assessing pain using facial recognition software among Aboriginal aged care residents with cognitive impairment: A retrospective cohort study.
Rissel C, Tate N, Moore L, et al. · Australas J Ageing · 2023
- Assessing AI Feasibility for Pain Evaluation in Hospitalized Cognitively Impaired Older Adults.
Dunwoody D, Prentice D, Thomson G, et al. · Pain Manag Nurs · 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.